Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 6, 2017)
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to prevent an application for a new drug from being considered ineligible for approval because its labeling includes information describing abuse-deterrent properties that otherwise would be blocked by market exclusivity provisions.
The Department of Health and Human Services shall issue draft guidance and publish final guidance regarding the award and scope of exclusivity for new drugs with properties designed to deter abuse and the exceptions to such exclusivity.
The bill applies to applications and supplements to applications that are submitted or pending approval on or after January 1, 2017.
What just happenedApr 7, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 6, 2017
- Apr 7, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 6, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 6, 2017IntroReferralIntro-H
Introduced in House
- Apr 6, 2017IntroReferral1000
Introduced in House